Neovacs S.A Operative Marge
Was ist das Operative Marge von Neovacs S.A?
Operative Marge von Neovacs S.A. ist -12,000.00%
Was ist die Definition von Operative Marge?
Die operative Marge ist das Verhältnis von Betriebseinkommen zu Nettomsatz und in Prozent dargestellt.
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operative Marge von Unternehmen in Health Care Sektor auf EURONEXT im Vergleich zu Neovacs S.A
Was macht Neovacs S.A?
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Unternehmen mit operative marge ähnlich Neovacs S.A
- BrainChip Ltd hat Operative Marge von -12,387.93%
- Stavely Minerals hat Operative Marge von -12,305.56%
- Key Petroleum hat Operative Marge von -12,250.00%
- Aurora Labs hat Operative Marge von -12,061.49%
- Constellation Resources hat Operative Marge von -12,049.12%
- Ovid Therapeutics Inc hat Operative Marge von -12,008.28%
- Neovacs S.A hat Operative Marge von -12,000.00%
- Verb Technology hat Operative Marge von -11,788.24%
- Albion Resources Ltd hat Operative Marge von -11,571.46%
- Golden Mile Resources hat Operative Marge von -11,516.67%
- Internet of Things hat Operative Marge von -11,511.14%
- Predictiv AI hat Operative Marge von -11,511.14%
- genedrive plc hat Operative Marge von -11,459.18%